BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21386091)

  • 1. Clinical outcomes in patients with the concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention: an analysis from the Guthrie Health Off-Label Stent (GHOST) investigators.
    Harjai KJ; Shenoy C; Orshaw P; Usmani S; Boura J; Mehta RH
    Circ Cardiovasc Interv; 2011 Apr; 4(2):162-70. PubMed ID: 21386091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
    Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study.
    Kreutz RP; Stanek EJ; Aubert R; Yao J; Breall JA; Desta Z; Skaar TC; Teagarden JR; Frueh FW; Epstein RS; Flockhart DA
    Pharmacotherapy; 2010 Aug; 30(8):787-96. PubMed ID: 20653354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.
    Banerjee S; Weideman RA; Weideman MW; Little BB; Kelly KC; Gunter JT; Tortorice KL; Shank M; Cryer B; Reilly RF; Rao SV; Kastrati A; de Lemos JA; Brilakis ES; Bhatt DL
    Am J Cardiol; 2011 Mar; 107(6):871-8. PubMed ID: 21247527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.
    Burkard T; Kaiser CA; Brunner-La Rocca H; Osswald S; Pfisterer ME; Jeger RV;
    J Intern Med; 2012 Mar; 271(3):257-63. PubMed ID: 21726302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major adverse cardiac events among postpercutaneous coronary intervention patients on clopidogrel and proton pump inhibitors.
    Ching GG; Li D; Baker WL; Hohl PK; Mather JF; McKay RG; Lundbye JB
    Conn Med; 2012 Apr; 76(4):205-11. PubMed ID: 22611719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
    Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
    Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors.
    Sarafoff N; Sibbing D; Sonntag U; Ellert J; Schulz S; Byrne RA; Mehilli J; Schömig A; Kastrati A
    Thromb Haemost; 2010 Sep; 104(3):626-32. PubMed ID: 20664905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
    Lettino M
    Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the concomitant use of clopidogrel and Proton Pump Inhibitors still associated with increased adverse cardiovascular outcomes following coronary angioplasty?: a systematic review and meta-analysis of recently published studies (2012 - 2016).
    Bundhun PK; Teeluck AR; Bhurtu A; Huang WQ
    BMC Cardiovasc Disord; 2017 Jan; 17(1):3. PubMed ID: 28056809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention.
    Huang CC; Chen YC; Leu HB; Chen TJ; Lin SJ; Chan WL; Chen JW
    Am J Cardiol; 2010 Jun; 105(12):1705-9. PubMed ID: 20538118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Interaction between clopidogrel and proton pump inhibitors.
    Howard PA; Vacek JL
    Am J Cardiovasc Drugs; 2009; 9(6):353-9. PubMed ID: 19929033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of clopidogrel and proton pump inhibitors in patients undergoing drug-eluting stent implantation.
    Rossini R; Capodanno D; Musumeci G; Lettieri C; Lortkipanidze N; Romano M; Nijaradze T; Tarantini G; Cicorella N; Sirbu V; Guagliumi G; Rosiello R; Valsecchi O; Gavazzi A
    Coron Artery Dis; 2011 May; 22(3):199-205. PubMed ID: 21358542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy.
    Zuern CS; Geisler T; Lutilsky N; Winter S; Schwab M; Gawaz M
    Thromb Res; 2010 Feb; 125(2):e51-4. PubMed ID: 19781742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clopidogrel and proton pump inhibitors: is there a significant drug-drug interaction?
    Shmulevich E; Friger M; Gilutz H; Azab AN
    Can J Cardiovasc Nurs; 2011; 21(4):27-36. PubMed ID: 22165503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndrome.
    Persson J; Lindbäck J; Hofman-Bang C; Lagerqvist B; Stenestrand U; Samnegard A
    EuroIntervention; 2011 Apr; 6(9):1046-52, 8-9. PubMed ID: 21518675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan.
    Lin CF; Shen LJ; Wu FL; Bai CH; Gau CS
    Br J Clin Pharmacol; 2012 Nov; 74(5):824-34. PubMed ID: 22364155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
    Sibbing D; Morath T; Stegherr J; Braun S; Vogt W; Hadamitzky M; Schömig A; Kastrati A; von Beckerath N
    Thromb Haemost; 2009 Apr; 101(4):714-9. PubMed ID: 19350116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomes.
    Gaglia MA; Torguson R; Hanna N; Gonzalez MA; Collins SD; Syed AI; Ben-Dor I; Maluenda G; Delhaye C; Wakabayashi K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2010 Mar; 105(6):833-8. PubMed ID: 20211327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.
    Ortolani P; Marino M; Marzocchi A; De Palma R; Branzi A
    J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):783-9. PubMed ID: 21252697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.